查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589604

药品安全市场：按功能、交付模式和最终用户划分 - 2025-2030 年全球预测

Drug Safety Market by Functionality (ADR Reporting, Drug Safety Audits, Fully Integrated Software), Delivery Mode (On-Demand, On-Premise), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年药品安全市场价值为115.6亿美元，预计到2024年将达到140.6亿美元，复合年增长率为21.70%，到2030年将达到457.4亿美元。

药品安全市场在製药业中发挥着至关重要的作用，其重点是透过识别、评估和减轻与药品使用相关的风险来确保药品的安全性、有效性和品质。药物安全考虑到严格的全球药物指南，对于防止副作用和确保监管合规性是必要的。应用范围从临床前测试到上市后监测，最终用户包括製药公司、监管机构、医疗保健提供者和患者。影响成长的关键因素包括慢性病盛行率上升、药物开发活动活性化、监管要求收紧以及在药物安全检测过程中采用人工智慧和巨量资料分析等先进技术。然而，市场面临安全测试和合规相关高成本、监管环境复杂以及核准流程冗长等限制。目前的商机在于个人化医疗的扩展，这需要更个人化的药物安全评估，以及更加重视以患者为中心的方法，从而推动对即时安全监测解决方案的需求。公司可以透过投资创新的安全管理解决方案和伙伴关係关係来抓住这些机会，以利用技术进步。此外，向医疗保健基础设施快速发展的新兴市场扩张也提供了良好的前景。创新和研究可以集中在整合机器学习和人工智慧，以简化安全流程，更有效地预测不利事件，并改善整体药物开发时间表。儘管存在资料隐私问题和国际监管差异等挑战，但增强安全通讯协定的颠覆性创新的市场已经成熟。随着越来越多的审查和对透明度的要求继续塑造这个充满活力的行业，保持领先地位需要利用技术整合和策略联盟来推动市场领导地位和永续成长。

主要市场统计
基准年[2023] 115.6亿美元
预测年份 [2024] 140.6亿美元
预测年份 [2030] 457.4亿美元
复合年增长率（%） 21.70%

市场动态：揭示快速发展的药品安全市场的关键市场洞察

供需的动态交互作用正在改变药品安全市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 吸烟人口增加
    • 增加病人安全问题
    • 企业对外包服务的需求增加
  • 市场限制因素
    • 临床试验问题
  • 市场机会
    • 活性化研发活动
    • 更多采用药物安全性来推动新药上市
  • 市场挑战
    • 药物的副作用

波特五力：驾驭药品安全市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解药品安全市场的外部影响

外部宏观环境因素对药品安全市场的绩效动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解药品安全市场的竞争格局

对药品安全市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵药物安全市场供应商的绩效评估

FPNV定位矩阵是评估药品安全市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

战略分析和建议绘製药品安全市场的成功之路

药品安全市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 吸烟成瘾的人口增加
      • 增加病人安全问题
      • 玩家对外包服务的需求增加
    • 抑制因素
      • 临床试验问题
    • 机会
      • 增加研发活动
      • 扩大药物安全的采用以加速新药上市
    • 任务
      • 药物副作用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 药品安全市场的功能

  • ADR报告
  • 药品安全审核
  • 完全整合的软体
  • 问题追踪

第七章 依交付方式分類的药品安全市场

  • 一经请求
  • 本地

第八章 药品安全市场：依最终使用者分类

  • 业务流程外包
  • 合约调查机构
  • 製药和生物技术公司

第九章美洲药品安全市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太药品安全市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲药品安全市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AB CUBE SAS
  • Accenture, plc
  • ArisGlobal LLC
  • Cinven
  • Cognizant Technology Solutions Corp
  • Ergomed PLC
  • EXTEDO GmbH
  • Genpact
  • HCL Technologies Limited
  • Indigene Pharmaceuticals, Inc.
  • IQVIA Inc.
  • Medco Health Solutions, Inc.
  • Oracle Corporation
  • Parexel International Corporation
  • PPD Inc
  • Sarjen Systems Pvt. Ltd
  • Sparta Systems Inc.
  • Syneos Health
  • Worldwide Clinical Trials
Product Code: MRR-030EE48515FE

The Drug Safety Market was valued at USD 11.56 billion in 2023, expected to reach USD 14.06 billion in 2024, and is projected to grow at a CAGR of 21.70%, to USD 45.74 billion by 2030.

The drug safety market plays a critical role in the pharmaceutical industry, focused on ensuring the safety, efficacy, and quality of drugs by identifying, evaluating, and mitigating risks associated with their use. Drug safety is necessary to prevent adverse effects and ensure regulatory compliance, given the stringent guidelines worldwide for pharmaceuticals. The application scope ranges from pre-clinical trials to post-marketing surveillance, with end-users including pharmaceutical companies, regulatory authorities, healthcare providers, and patients. Key influencing growth factors include the rising prevalence of chronic diseases, increasing drug development activities, heightened regulatory requirements, and the adoption of advanced technologies such as AI and big data analytics in pharmacovigilance processes. However, the market faces limitations, including high costs associated with safety testing and compliance, complex regulatory landscapes, and time-consuming approval processes. Current opportunities lie in the expansion of personalized medicine, which requires more tailored drug safety evaluations, and the growing emphasis on patient-centric approaches that drive demand for real-time safety monitoring solutions. Companies can seize these opportunities by investing in innovative safety management solutions and partnerships to leverage technological advancements. Additionally, expanding into emerging markets, where healthcare infrastructure is rapidly developing, presents lucrative prospects. Innovation and research can focus on integrating machine learning and AI to streamline safety processes, predicting adverse outcomes more efficiently, and improving overall drug development timelines. Despite challenges, such as data privacy concerns and varying international regulations, the market is ripe for disruptive innovations that enhance safety protocols. As heightened scrutiny and transparency demands continue to shape this dynamic sector, staying ahead requires a keen focus on technological integration and strategic collaborations to drive market leadership and sustainable growth.

KEY MARKET STATISTICS
Base Year [2023] USD 11.56 billion
Estimated Year [2024] USD 14.06 billion
Forecast Year [2030] USD 45.74 billion
CAGR (%) 21.70%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Safety Market

The Drug Safety Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing population addicted to smoking
    • Escalating patient safety issues
    • Rise in demand for outsourcing services by players
  • Market Restraints
    • Issues related to clinical trials
  • Market Opportunities
    • Rising R&D activities
    • Increasing adoption of drug safety facilitating the launch of new drugs
  • Market Challenges
    • Adverse effects of drugs

Porter's Five Forces: A Strategic Tool for Navigating the Drug Safety Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Safety Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Safety Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Safety Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Safety Market

A detailed market share analysis in the Drug Safety Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Safety Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Safety Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Safety Market

A strategic analysis of the Drug Safety Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Safety Market, highlighting leading vendors and their innovative profiles. These include AB CUBE S.A.S, Accenture, plc, ArisGlobal LLC, Cinven, Cognizant Technology Solutions Corp, Ergomed PLC, EXTEDO GmbH, Genpact, HCL Technologies Limited, Indigene Pharmaceuticals, Inc., IQVIA Inc., Medco Health Solutions, Inc., Oracle Corporation, Parexel International Corporation, PPD Inc, Sarjen Systems Pvt. Ltd, Sparta Systems Inc., Syneos Health, and Worldwide Clinical Trials.

Market Segmentation & Coverage

This research report categorizes the Drug Safety Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Functionality, market is studied across ADR Reporting, Drug Safety Audits, Fully Integrated Software, and Issue Tracking.
  • Based on Delivery Mode, market is studied across On-Demand and On-Premise.
  • Based on End User, market is studied across Business Process Outsourcing, Contract Research Organizations, and Pharma & Biotech Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing population addicted to smoking
      • 5.1.1.2. Escalating patient safety issues
      • 5.1.1.3. Rise in demand for outsourcing services by players
    • 5.1.2. Restraints
      • 5.1.2.1. Issues related to clinical trials
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising R&D activities
      • 5.1.3.2. Increasing adoption of drug safety facilitating the launch of new drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse effects of drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug Safety Market, by Functionality

  • 6.1. Introduction
  • 6.2. ADR Reporting
  • 6.3. Drug Safety Audits
  • 6.4. Fully Integrated Software
  • 6.5. Issue Tracking

7. Drug Safety Market, by Delivery Mode

  • 7.1. Introduction
  • 7.2. On-Demand
  • 7.3. On-Premise

8. Drug Safety Market, by End User

  • 8.1. Introduction
  • 8.2. Business Process Outsourcing
  • 8.3. Contract Research Organizations
  • 8.4. Pharma & Biotech Companies

9. Americas Drug Safety Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug Safety Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug Safety Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AB CUBE S.A.S
  • 2. Accenture, plc
  • 3. ArisGlobal LLC
  • 4. Cinven
  • 5. Cognizant Technology Solutions Corp
  • 6. Ergomed PLC
  • 7. EXTEDO GmbH
  • 8. Genpact
  • 9. HCL Technologies Limited
  • 10. Indigene Pharmaceuticals, Inc.
  • 11. IQVIA Inc.
  • 12. Medco Health Solutions, Inc.
  • 13. Oracle Corporation
  • 14. Parexel International Corporation
  • 15. PPD Inc
  • 16. Sarjen Systems Pvt. Ltd
  • 17. Sparta Systems Inc.
  • 18. Syneos Health
  • 19. Worldwide Clinical Trials

LIST OF FIGURES

  • FIGURE 1. DRUG SAFETY MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG SAFETY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG SAFETY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG SAFETY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG SAFETY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG SAFETY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRUG SAFETY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DRUG SAFETY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DRUG SAFETY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DRUG SAFETY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DRUG SAFETY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DRUG SAFETY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DRUG SAFETY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG SAFETY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG SAFETY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG SAFETY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG SAFETY MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG SAFETY MARKET SIZE, BY ADR REPORTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG SAFETY MARKET SIZE, BY DRUG SAFETY AUDITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG SAFETY MARKET SIZE, BY FULLY INTEGRATED SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG SAFETY MARKET SIZE, BY ISSUE TRACKING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG SAFETY MARKET SIZE, BY ON-DEMAND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG SAFETY MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG SAFETY MARKET SIZE, BY BUSINESS PROCESS OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG SAFETY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG SAFETY MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES DRUG SAFETY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. DRUG SAFETY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. DRUG SAFETY MARKET, FPNV POSITIONING MATRIX, 2023